rs80338697
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_138477.4(CDAN1):c.3124C>T(p.Arg1042Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000125 in 1,445,592 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.000012 ( 0 hom. )
Consequence
CDAN1
NM_138477.4 missense
NM_138477.4 missense
Scores
7
9
3
Clinical Significance
Conservation
PhyloP100: 1.70
Genes affected
CDAN1 (HGNC:1713): (codanin 1) This gene encodes a protein that appears to play a role in nuclear envelope integrity, possibly related to microtubule attachments. Mutations in this gene cause congenital dyserythropoietic anemia type I, a disease resulting in morphological and functional abnormalities of erythropoiesis. [provided by RefSeq, Jul 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.979
PP5
Variant 15-42726390-G-A is Pathogenic according to our data. Variant chr15-42726390-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3176.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDAN1 | NM_138477.4 | c.3124C>T | p.Arg1042Trp | missense_variant | 24/28 | ENST00000356231.4 | NP_612486.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDAN1 | ENST00000356231.4 | c.3124C>T | p.Arg1042Trp | missense_variant | 24/28 | 1 | NM_138477.4 | ENSP00000348564.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152262Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
152262
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000909 AC: 2AN: 219914Hom.: 0 AF XY: 0.00000840 AC XY: 1AN XY: 119116
GnomAD3 exomes
AF:
AC:
2
AN:
219914
Hom.:
AF XY:
AC XY:
1
AN XY:
119116
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000125 AC: 18AN: 1445592Hom.: 0 Cov.: 32 AF XY: 0.0000125 AC XY: 9AN XY: 717618
GnomAD4 exome
AF:
AC:
18
AN:
1445592
Hom.:
Cov.:
32
AF XY:
AC XY:
9
AN XY:
717618
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Alfa
AF:
Hom.:
ExAC
AF:
AC:
2
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Anemia, congenital dyserythropoietic, type 1a Pathogenic:2Other:1
not provided, no classification provided | literature only | GeneReviews | - | Founder variant in Bedouin population - |
Likely pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | May 04, 2022 | The homozygous p.Arg1042Trp variant in CDAN1 was identified by our study in 1 individual with anemia, congenital dyserythropoietic, type 1a. The variant has been reported in at least 10 Israeli Bedouin individuals with anemia, congenital dyserythropoietic, type 1a (PMID: 12434312, 18081704), segregated with disease in at least 4 affected relatives from at least one family (PMID: 12434312), and has been identified in 0.01% (1/9396) of Ashkenazi Jewish and 0.006% (1/16548) of East Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs80338697). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. This variant has also been reported in ClinVar (Variation ID: 3176) as pathogenic by OMIM, GeneReviews, and CeGaT Praxis fuer Humangenetik Tuebingen. In vitro functional studies provide some evidence that the p.Arg1042Trp variant may impact protein function (PMID: 22407294). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The presence of this variant in at least 10 affected homozygotes, and in at least 10 individuals with anemia, congenital dyserythropoietic, type 1a increases the likelihood that the p.Arg1042Trp variant is pathogenic (PMID: 12434312, 18081704). Multiple variants in the same region as p.Arg1042Trp have been reported in association with disease, suggesting that this variant is in a hot spot and slightly supports pathogenicity (PMID: 18081704). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PP1_strong, PM3, PM1_supporting, PS3_supporting, PP3 (Richards 2015). - |
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | May 20, 2023 | The missense variant c.3124C>T (p.Arg1042Trp) in the CDAN1 gene has been reported previously in homozygous state in multiple individuals affected with Congenital dyserythropoietic anaemia. This variant is considered as a founder mutation in Israeli Bedouin patients. In vitro, functional studies provide some evidence that the p.Arg1042Trp variant may impact protein function (Ask et al., 2012; Tamary et al., 2008; Dgany et al., 2002). This variant is reported with the allele frequency (0.0009%) in the gnomAD. It is submitted to ClinVar with varying interpretations as Pathogenic/Likely Pathogenic. The amino acid Arginine at position 1042 is changed to a Tryptophan changing protein sequence and it might alter its composition and physico-chemical properties. Multiple lines of computational evidence (Polyphen - Damaging, SIFT - Damaging) predict a damaging effect on protein structure and function for this variant. The amino acid change p.Arg1042Trp in CDAN1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic. - |
Congenital dyserythropoietic anemia, type I Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 2002 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MutPred
Loss of solvent accessibility (P = 6e-04);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at